All companies
LO
Longbio B
01779IPO Upcoming
IPO UpcomingHong Kong(SEHK)Best valuation —0 markets
Official IPO
Priced· SEHK· Listing market: Hong KongPriced
Jun 4, 2026
IPO price
—
Shares offered
—
Raise
—
Sources: hkex
No quoted sources for this company yet.
About Longbio B
Longbio B is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Longbio B belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.